Due diligence report
Documentation review report
Report ID: demo-2 · Generated: 2026-05-28
Executive summary
Documentation review covering 5 batch records across 2 suppliers with lower completeness scores. Baltic Peptide Documentation Co. (71%) has an active dispute and retest request in progress. Meridian Reference Standards (83%) has one batch at supplier-uploaded status only. Significant documentation gaps exist. Procurement teams should await resolution of the Baltic dispute and Meridian lab review before making sourcing decisions based on these records.
Demo only — no real PDF generated. For illustration purposes only.
Supplier completeness
Baltic Peptide Documentation Co.
listedMeridian Reference Standards
under-reviewDocumentation gaps
- ⚠Baltic PT-141 batch (PL-BP-260509-LCMS15): active dispute — batch number inconsistency
- ⚠Baltic Epithalon batch (PL-BP-260506-HPLC14): retest requested, result pending
- ⚠Meridian GHRP-6 batch (PL-MR-260513-HPLC17): supplier-uploaded only, no review initiated
Batches reviewed
PL-BP-260512-LCMS13
TB-500 (Research Reference)
Baltic Peptide Documentation Co.
PL-BP-260506-HPLC14
Epithalon (Research Reference)
Baltic Peptide Documentation Co.
PL-BP-260509-LCMS15
PT-141 (Research Reference)
Baltic Peptide Documentation Co.
PL-MR-260518-LCMS16
Hexarelin (Research Reference)
Meridian Reference Standards
PL-MR-260513-HPLC17
GHRP-6 (Research Reference)
Meridian Reference Standards
Suppliers in scope
Meridian Reference Standards
Singapore · 2 batches
PurityLedger provides documentation review, batch record hosting, CoA verification tools and analytical testing coordination only. PurityLedger does not certify any product as safe, effective, legal, approved, or suitable for human or veterinary use. Testing records are batch-specific and do not constitute medical advice, regulatory approval, or endorsement of any supplier or product. Clients and users are responsible for compliance with applicable laws in their jurisdiction.